The Role of CSF in Alzheimer's Disease - Insights
This "Specialty Testing" webinar will discuss Cerebrospinal fluid (CSF), which has been used in research on Alzheimer's disease for decades. Only recently, have platforms been developed to standardize measurements across laboratories.
Week in Review: March 31 - Insights
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.
Dr. Morice shares with Lab Manager how clinical labs can advance health equity - Insights
Clinical labs are key to advancing health equity, reducing barriers, and improving access through innovation, collaboration, and community engagement. Dr. Morice shares his thoughts in the Lab Manager article, “Health Equity Starts in the...
Autoimmune Myelopathy Evaluation [Test in Focus] - Insights
Patients with autoimmune myelopathy present with subacute onset and rapid progression of spinal cord symptoms (weakness, gait difficulties, loss of sensation, neuropathic pain, and bowel and bladder dysfunction). Autoimmune myelopathy...
Holiday Specimen Shipment - Insights
Due to the Labor Day holiday (recognized on Monday, September 7), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected.
Week in Review: April 7 - Insights
Top highlights include: Government to launch $300M Azlheimer's research database, new COVID variant XBB.1.16 spotted in 18 US states, and novel treatment shows promise against rare cancer in kids.
Week in Review: February 10 - Insights
Today's Highlights Include: USDA proposes new nutrition standards for school meals, virtual care system designed for COVID-19 grows into a multiuse digital health tool, and Mayo Clinic explores use of artificial intelligence. Is It Hype Or...
Test Catalog Specimen Rejection Information Update - Insights
The “Reject Due To” information contained in our online test catalog is being updated to provide greater clarity around rejection standards.
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections.
Lyme Neuroborreliosis - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss diagnostic testing options for patients with suspected neuroinvasive Lyme disease or Lyme neuroborreliosis.